We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Asymptomatic Individuals May Shed Infective Leptospira Bacteria in Their Urine

By LabMedica International staff writers
Posted on 09 Mar 2016
An international team of molecular microbiologists has assembled a comprehensive, cross-species genomic comparison of all 20 known species of Leptospira and determined that a pool of asymptomatic individuals was shedding the bacteria in their urine. More...


The more than 200 types of spiral-shaped bacteria (spirochetes) in the genus Leptospira are classified as pathogenic, intermediately pathogenic, or saprophytic based on their ability to cause disease and on genetic information.

In humans, approximately 90% of cases of the disease are mild leptospirosis. Others experience a severe form of the disease known as Weil's disease, which is characterized by liver damage (causing jaundice), kidney failure, and bleeding. Additionally, the heart and brain can be affected; meningitis of the outer layer of the brain, encephalitis of brain tissue with same signs and symptoms; and lung affected as the most serious and life-threatening of all leptospirosis complications. The infection is often incorrectly diagnosed due to the nonspecific symptoms.

An international team of molecular microbiologists sought evidence for human reservoirs of the bacteria and for genetic clues as to why it caused such a broad range of symptoms among infected individuals. The investigators from the United States, Australia, France, England, The Netherlands, Canada, Uruguay, Brazil, Peru, and Thailand used a combination of epidemiological data, serology, and molecular detection of the leptospiral 16S rRNA gene to identify asymptomatic urinary shedders of Leptospira among the inhabitants of a rural village in the Peruvian Amazon region.

They reported in the February 23, 2016, online edition of the journal PLOS Neglected Tropical Diseases that approximately one-third of 314 asymptomatic participants had circulating anti-leptospiral antibodies. Among enrolled participants, 189 (59%) had evidence of recent infection. Among these people, 13 (all women) had Leptospira DNA-positive urine samples. A group of 102 long-term asymptomatic individuals without serological evidence of recent infection was identified. Within this group, six (5.9%) excreted pathogenic and intermediate-pathogenic Leptospira in their urine.

The results showed that asymptomatic renal colonization of Leptospira bacteria in a region of high disease transmission was common, including among people without serological or clinical evidence of recent infection. Both pathogenic and intermediate Leptospira could persist as renal colonization in humans.

Leptospira is the most complex genus of bacteria that infects humans,” said senior author Dr. Joseph M. Vinetz, professor of medicine at the University of California, San Diego (USA). “This work compares the complete genome sequences of all known species of Leptospira to discover which genes make this bacterium a pathogen. It provides a roadmap for future research, including finding new ways to diagnose infection and vaccine development.”

“One fascinating finding was discovering the CRISPR-Cas genetic machinery only in pathogenic Leptospira, but not in the intermediate or non-infectious groups of the genus. The evolutionary acquisition of novel CRISPR elements, which are only in pathogenic Leptospira, probably hastened adaptation to human infection. The significance of this observation remains to be explored,” said Dr. Vinetz.

Related Links:

University of California, San Diego



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.